Study inclusion criteria and presentation of results in a meta-analysis of granulocyte colony-stimulating factor for prevention of febrile neutropenia.

TO THE EDITOR: Febrile neutropenia is a potentially lifethreatening toxicity associated with chemotherapy. A systematic review and meta-analysis by Kuderer et al presented clinical trials investigating the use of granulocyte colony-stimulating factor (GCSF) as primary prophylaxis to prevent febrile neutropenia and its associated mortality. Their study… CONTINUE READING